|
sars-cov-2 |
54 |
|
covid-19 |
53 |
|
coronavirus |
36 |
|
sars-cov |
29 |
|
lipidomics |
25 |
|
pathogenesis |
23 |
|
antiviral |
22 |
|
viral replication |
22 |
|
influenza a virus |
21 |
|
interferon |
21 |
|
enterovirus |
20 |
|
mers-cov |
18 |
|
inhibitor |
17 |
|
animal |
16 |
|
fatty acid |
16 |
|
flavivirus |
16 |
|
hamster |
16 |
|
hemagglutinin |
16 |
|
uplc-esi-q-tof-ms |
16 |
|
influenza virus |
15 |
|
omicron |
15 |
|
vaccine |
15 |
|
age |
14 |
|
immune activation |
14 |
|
intestine |
14 |
|
pathogenicity |
14 |
|
replication |
14 |
|
bunyavirales |
13 |
|
cytokine and chemokine response |
13 |
|
sars-cov-2 variants |
13 |
|
treatment |
13 |
|
h5n1 |
12 |
|
infectivity |
12 |
|
sftsv |
12 |
|
transmission |
12 |
|
2′-o-methyltransferase |
11 |
|
animal cell |
11 |
|
animal tissue |
11 |
|
anthranilic acid |
11 |
|
ba.5.2 |
11 |
|
bat |
11 |
|
broad spectrum |
11 |
|
coronavirus disease 2019 |
11 |
|
endoplasmic reticulum |
11 |
|
entry |
11 |
|
feces analysis |
11 |
|
human immunodeficiency virus |
11 |
|
live attenuated vaccine |
11 |
|
mouse |
11 |
|
mucosal immunity |
11 |
|
murine |
11 |
|
n501y |
11 |
|
nsp16 |
11 |
|
rat |
11 |
|
sterilizing immunity |
11 |
|
susceptibility |
11 |
|
t-cell response |
11 |
|
adult |
10 |
|
antigen-presentation |
10 |
|
apoptosis |
10 |
|
child |
10 |
|
china |
10 |
|
coronavirus - immunology - pathogenicity - physiology |
10 |
|
coronavirus infections - immunology - virology |
10 |
|
cytokines - biosynthesis - immunology |
10 |
|
damplicon |
10 |
|
linker-immunodominant site |
10 |
|
pneumonia, viral - immunology - virology |
10 |
|
spike protein |
10 |
|
virus replication - physiology |
10 |
|
aged mice |
9 |
|
airborne infection |
9 |
|
airway organoid |
9 |
|
animal experiment |
9 |
|
animal model |
9 |
|
antibody-dependent cell-mediated cytotoxicity |
9 |
|
bagg albino mouse |
9 |
|
bioaerosols |
9 |
|
cell surface |
9 |
|
circrna |
9 |
|
clinical outcome |
9 |
|
controlled study |
9 |
|
coronavac |
9 |
|
ex vivo |
9 |
|
ex vivo human lung tissues |
9 |
|
fc-rbd |
9 |
|
genome mutation |
9 |
|
h1n1 influenza virus |
9 |
|
human primary nasal epithelial cells |
9 |
|
human respiratory syncytial virus |
9 |
|
internalization |
9 |
|
lethal mouse model |
9 |
|
lung damage |
9 |
|
lung pathology |
9 |
|
mice |
9 |
|
mrna |
9 |
|
neutralizing antibody |
9 |
|
nucleolin |
9 |
|
omicron variant |
9 |
|
operating rooms |
9 |
|
pb2 |
9 |
|
phosphatidic acid phosphatases |
9 |
|
post-ba.2/5 subvariants |
9 |
|
proximal differentiation |
9 |
|
reverse genetics |
9 |
|
temperature |
9 |
|
vopba |
9 |
|
weanling mice |
9 |
|
xbb.1 |
9 |
|
25-hydroxycholesterol |
8 |
|
3clpro inhibitor |
8 |
|
allosteric-site inhibitor |
8 |
|
am580 |
8 |
|
animal models |
8 |
|
balb/c mice |
8 |
|
broad-spectrum antiviral treatment |
8 |
|
caspase |
8 |
|
cattle |
8 |
|
chemical genetics |
8 |
|
clade 2.3.4.4b |
8 |
|
dendritic cells |
8 |
|
high throughput screening |
8 |
|
macrophages |
8 |
|
mammary gland |
8 |
|
marmosets |
8 |
|
mask |
8 |
|
ns5 |
8 |
|
spike mutant |
8 |
|
spike s1/s2 mutant |
8 |
|
spleen |
8 |
|
t lymphocytes |
8 |
|
tonsil |
8 |
|
a(h1n1)pdm09 influenza |
7 |
|
a(h7n9) influenza |
7 |
|
adenosine synthase a |
7 |
|
adjuvant |
7 |
|
anti-influenza |
7 |
|
coinfection |
7 |
|
combination therapy |
7 |
|
corticosteroid |
7 |
|
cross-protection |
7 |
|
cva16 |
7 |
|
endonuclease activity |
7 |
|
ev-a71 |
7 |
|
genetic variation |
7 |
|
h7n7 virus |
7 |
|
hcov-229e |
7 |
|
high infection rate |
7 |
|
influenza vaccine |
7 |
|
interferon antagonist |
7 |
|
intestinal organoids |
7 |
|
ire1 |
7 |
|
lung eqtl |
7 |
|
mdms |
7 |
|
miltefosine |
7 |
|
modcs |
7 |
|
monoinfection |
7 |
|
ms |
7 |
|
mutation |
7 |
|
neurogenesis |
7 |
|
nlrp3 inflammasome |
7 |
|
nsp3 |
7 |
|
olfactory neuron |
7 |
|
orf6 |
7 |
|
pa protein |
7 |
|
pan-a37s |
7 |
|
pan-a37s/i61t |
7 |
|
pan-a37s/v63i |
7 |
|
plpro |
7 |
|
polymerase activity |
7 |
|
polymerase assembly |
7 |
|
protease |
7 |
|
remdesivir |
7 |
|
route of transmission |
7 |
|
spermatogenesis |
7 |
|
stability |
7 |
|
staphylococcus aureus |
7 |
|
t cell responses |
7 |
|
tfh |
7 |
|
tmprss2 |
7 |
|
uhplc |
7 |
|
upr |
7 |
|
zika virus |
7 |
|
antigenic cartography |
6 |
|
antigenic distance |
6 |
|
antigenic field |
6 |
|
ar-12 |
6 |
|
artenimol |
6 |
|
booster vaccine |
6 |
|
brain |
6 |
|
broxyquinoline |
6 |
|
clr |
6 |
|
common marmoset |
6 |
|
eltrombopag |
6 |
|
emerging |
6 |
|
genome |
6 |
|
hexachlorophene |
6 |
|
hsp90β |
6 |
|
huaiyangshan banyangvirus |
6 |
|
immune imprinting |
6 |
|
interactome |
6 |
|
intestinal |
6 |
|
kaletra |
6 |
|
kinase |
6 |
|
lopinavir |
6 |
|
mers |
6 |
|
mincle |
6 |
|
mycophenolate |
6 |
|
newly-weaned hamster |
6 |
|
nucleoprotein |
6 |
|
omacetaxine mepesuccinate |
6 |
|
organoids |
6 |
|
peptide |
6 |
|
platform |
6 |
|
primate |
6 |
|
proinflammatory response |
6 |
|
regorafenib |
6 |
|
rlr |
6 |
|
sars |
6 |
|
sars-cov-1 |
6 |
|
sfstv |
6 |
|
tick |
6 |
|
triclosan |
6 |
|
vaccine seed strain selection |
6 |
|
wuhan |
6 |
|
zika |
6 |
|
acly |
5 |
|
alveolar-bronchiolization |
5 |
|
antiviral peptide |
5 |
|
ba.2.12.1 |
5 |
|
basal cell |
5 |
|
competing endogenous rna |
5 |
|
delta |
5 |
|
eif4g1 |
5 |
|
f486v |
5 |
|
glucose homeostasis |
5 |
|
hnpcs |
5 |
|
host−virus interaction |
5 |
|
ido1 |
5 |
|
indoleamine 2,3-dioxygenase |
5 |
|
library |
5 |
|
long covid-19 |
5 |
|
metabolic profiling |
5 |
|
metabolomics |
5 |
|
mirna |
5 |
|
neutralizing antibodies |
5 |
|
pasc |
5 |
|
tat |
5 |
|
type-ii ifn |
5 |
|
cell death |
4 |
|
class iii pi3-k |
4 |
|
cytokines |
4 |
|
drug susceptibility |
4 |
|
h7n9 |
4 |
|
hnrnp c |
4 |
|
ifn |
4 |
|
immune breakthrough |
4 |
|
innate immune response |
4 |
|
modelling |
4 |
|
monocytes |
4 |
|
pb2-k389r |
4 |
|
pb2-v598t/i |
4 |
|
re-infection |
4 |
|
replication capacity |
4 |
|
rna binding protein |
4 |
|
vaccination |
4 |
|
virulence |
4 |
|
vps34 |
4 |
|
interferon signaling |
3 |
|
stat1 |
3 |
|
prevent transmission |
2 |
|
superneut mask |
2 |
|
syrian hamster model |
2 |
|
air pollution |
1 |
|
bnabs |
1 |
|
casein kinase ii |
1 |
|
fip1c |
1 |
|
hantaan virus |
1 |
|
hiv assembly |
1 |
|
hiv envelope |
1 |
|
hiv-1 |
1 |
|
hofbauer cells |
1 |
|
mtct |
1 |
|
nucleocapsid protein |
1 |
|
phosphorylation |
1 |
|
placenta |
1 |
|
pseudotyping |
1 |
|
rab coupling protein |
1 |
|
respiratory infection |
1 |
|
secondary organic aerosol |
1 |
|
vccs |
1 |
|
virus |
1 |
